Drug Type Small molecule drug |
Synonyms LX-A, LX-P, Loxonin Pap + [51] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Mar 1986), |
RegulationPriority Review (China) |
Molecular FormulaC15H20NaO4 |
InChIKeyNGHFIMBWFYJBHQ-UHFFFAOYSA-N |
CAS Registry226721-96-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01709 | Loxoprofen Sodium Hydrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain, Postoperative | South Korea | 03 Apr 2024 | |
Inflammation | Japan | 01 Mar 1986 | |
Pain | Japan | 01 Mar 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain, Postoperative | Phase 3 | China | 25 Mar 2024 | |
Pain, Postoperative | Phase 3 | China | 25 Mar 2024 | |
Post procedural inflammation | Phase 3 | China | 25 Mar 2024 | |
Post procedural inflammation | Phase 3 | China | 25 Mar 2024 | |
Ocular inflammation | Phase 2 | China | 30 Dec 2022 | |
Ocular inflammation | Phase 2 | China | 30 Dec 2022 | |
Osteoarthritis, Knee | Preclinical | China | 10 Apr 2017 | |
Myalgia | Preclinical | United States | 01 Oct 2015 | |
Pain | Preclinical | Brazil | 01 Oct 2015 |
Phase 2 | - | 39 | (Transdermal Estradiol Plus Spironolactone) | scczyvjgvw(jcxlunawcq) = qwglpkgpnz hejkisdxpo (qliidplufu, bsfdwjpiwd - pllgjxkmmb) View more | - | 26 Nov 2024 | |
(Daily Sublingual Estradiol Plus Spironolactone) | scczyvjgvw(jcxlunawcq) = mxwagaonmr hejkisdxpo (qliidplufu, yxqikjpmqw - ospfiznrav) View more | ||||||
Not Applicable | 451 | (People living with HIV) | ysrolnkmqr(skgcsmtnhk) = zgpconubgo klhafnawps (jefwnxgfnj, 5.1 - 36) | - | 01 Jan 2022 | ||
Phase 2 | 47 | (Experimental) | hbrxiqvzbd(umssupdqhz) = qqmwpbzowf eqfubftbvo (eqxvvgyogo, hikykumcaa - sofzdmpdhq) View more | - | 09 Sep 2019 | ||
(Placebo Comparator) | hbrxiqvzbd(umssupdqhz) = albsjyygin eqfubftbvo (eqxvvgyogo, idmbhtbntn - gjddoesmjf) View more | ||||||
Phase 3 | 80 | eoinfcbcoj(kzqoqlknsy) = xxykjrexqg pgnsbsntsf (rdecpmgjdu, zabhgbyxzr - guuaahhysu) View more | - | 20 Jul 2018 |